Use of etiotropic and pathogenetic medicines for COVID-19 in patients with renal failure and/or on dialysis

Abstract

Impaired kidney function may influence pharmacokinetics of most of the drugs, including the ones used in COVID-19. In this publication, the most important pharmacokinetic parameters and dose adjustment approaches are provided, based on The Renal Drug Handbook и Sanford Guide. In the majority of cases, mild kidney function reduction does not necessitate dose adjustment. Each case should be considered individually, measuring benefits against risks.

Keywords

• коронавирус
• хроническая почечная недостаточность
• диализ
• covid-19